Investor Alert: Class Actions Filed Against HireRight, Ocugen, Sonder, and QuidelOrtho

NEW YORK – Investors have been alerted to the initiation of class action lawsuits concerning several companies, including HireRight Holdings Corporation HRT, Ocugen, Inc. OCGN, Sonder Holdings Inc. SOND, and Quidel Corporation QDEL. The legal firm Bragar Eagel & Squire, P.C., operating at a national level in protecting shareholder rights, has issued a reminder to the shareholders of these companies that legal proceedings have commenced.

HireRight Holdings Corporation HRT

HireRight Holdings Corporation, operating under the symbol HRT, forms part of Arrhythmia Research Technology, Inc., which, through its wholly-owned subsidiary Micron Products, Inc., functions as a diversified manufacturer. Their services range from plastic molding and precision machining to the coating of precious metals within Massachusetts.

Ocugen, Inc. OCGN

Ocugen, Inc., trading as OCGN, is a clinical-stage biopharmaceutical enterprise focusing on gene therapy innovations to treat ocular diseases leading to blindness. The company prides itself on its pioneering spirit in healthcare and is based out of Malvern, Pennsylvania.

Sonder Holdings Inc. SOND

San Francisco-based Sonder Holdings Inc., marked on the exchange as SOND, engages extensively in the hospitality industry. The company reimagines the hotel experience by integrating innovative technology with exceptional service.

Quidel Corporation QDEL

QDEL represents Quidel Corporation, a significant player in the development and manufacturing of diagnostic testing solutions. Their range includes testing for infectious diseases, cardiology, thyroid issues, eye health, and more, with a global reach from their San Diego headquarters.

Investors with interest in these stocks are encouraged to take note of the open class-action lawsuits and may wish to contact Bragar Eagel & Squire, P.C. for further information on these proceedings.

Investment, Legal, Alert